Gibson, Dunn & Crutcher LLP is advising Fluor Corporation on its offering. Fluor Corporation (NYSE: FLR) announced the pricing of $500 million aggregate principal amount of 1.125%...
You must be a Standard 1 Year member to access this content.
Sidley Austin is representing NuStar Energy L.P., and Gibson, Dunn & Crutcher is representing the underwriters in the offering. NuStar Energy L.P. (NYSE:NS) announced the pricing of...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP is serving as legal counsel to Dril-Quip, Inc and Stikeman Elliott LLP is acting as legal counsel to Great North on...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised March Capital on the transaction. Nile announced a $175 million Series C investment round co-led by March Capital and Sanabil Investments, with strategic...
You must be a Standard 1 Year member to access this content.
Gibson Dunn advises Canary Wharf Group on £535 million loan for Wood Wharf development. Canary Wharf Group closed a £535 million loan from investment firm Cain...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised CenterOak Partners LLC and its portfolio company Palmetto Exterminators on the transaction. CenterOak Partners LLC (“CenterOak”) announced its portfolio company Palmetto...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising the underwriters on the offering. Waste Management, Inc. (NYSE: WM) (“WM” or the “Company”) announced that it has priced a...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Biosynth in the transaction. Biosynth, a portfolio company of KKR, announced its acquisition of celares GmbH. The terms and conditions of the...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP is serving as legal counsel to Neurogene Inc. and Fenwick & West LLP is serving as legal counsel to Neoleukin Therapeutics,...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Mirum Pharmaceuticals, Cooley LLP is advising Travere Therapeutics, Inc. in the transaction. Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) and Travere...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is advising Apogee Therapeutics, Inc. in the offering. Apogee Therapeutics, Inc. (Nasdaq: APGE) announced the pricing of its upsized initial public offering...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher represented Hewlett Packard Enterprise Company, while Cravath represented the underwriters in the transaction. Hewlett Packard Enterprise Company executed its offering of $250...
You must be a Standard 1 Year member to access this content.
